Business
Easton Pharmaceuticals Announces That Revenue Generating Operations Have Commenced From Its Alliance Property and Businesses
Easton Pharmaceuticals Announces That Revenue Generating Operations Have Commenced From Its Alliance Property and Businesses.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\nTORONTO, ON, June 04, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) is pleased to announce that revenue generating operations have commenced on its Alliance Group property and businesses.  \n Easton’s JV partner, 1124123 Ontario Limited (o/a – Alliance Group) is pleased to announce that revenues have commenced on its Georgina property, located just north of Toronto, Ontario, Canada. After delays resulting from various factors including poor early spring weather conditions, heavy machinery having a value in excess of $2 million were delivered to the property which resulted with the commencement of operations last week with revenues in excess of $20,000 in its first 2 days. This revenue marks the beginning of several business segments that will be carried out from the property. The first business is soil, while the company is gearing up for operations to soon commence from its aggregate business and marijuana production. Easton Pharmaceuticals and Alliance Group will be providing many more detailed updates in the coming weeks on revenue generation and future projections which can now be booked on Easton’s financial statements. Other future updates will include updates / changes to existing / new acquisitions and businesses, changes and new additions to its management team, Easton moving forward with Alliances medical / recreational marijuana operations as well as moving forward with audited financial statements and its retaining of an auditor now that revenues have commenced with Alliance Group and the expected revenues from Easton / BMV Medica’s sub-distribution Agreement recently executed with BAYER and the legal entity for its subsidiary company, BAYER Consumer Care for its woman’s diagnostic product known as VS-Sense for the country of Mexico.  Easton Pharmaceuticals executed an agreement with 1124123 Ontario Limited (o/a – Alliance Group) in June of 2017 where it advanced $1.3 million in Canadian currency to Alliance Group towards property and several businesses. Easton is pleased to have demonstrated that this investment and partnership with Alliance is now starting to generate revenues as planned when it entered into the transaction and is expecting substantial revenue based on commitments received to date. About Easton Pharmaceutica...